ArticleStroke2015

Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.

Jia Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.